背景如何影响临床试验:多国定性案例比较诊断生物标志物检测干预
该研究通过多国定性案例比较,分析缅甸仰光、泰国清莱和越南河内CRP即时检测试验中影响干预效果的情境因素。归纳出感知感染风险、卫生系统情境和需求侧情境三个主要域,分别影响临床使用者依从性、干预结局和患者依从性及排除。强调情境变异对解读临床试验发现的重要性,建议试验收集定性和定量情境信息。
要点
- 感知感染风险影响护士和医生对CRP检测结果的依从性。
- 卫生系统政策与结构通过利用模式影响全部三项干预结局。
- 需求侧情境(就医行为、疾病观念)影响患者依从性和排除。
核心结论
- 情境变异对解读临床试验发现至关重要。
- 需通过大型临床试验荟萃分析研究情境效应的范围与幅度。
- 临床试验应收集疾病、卫生系统和需求侧环境的定性与定量情境信息。
研究设计与样本
- 多国定性案例比较研究,比较仰光、清莱和河内CRP即时检测试验。
- 定性数据来自各临床试验,合成130名访谈和焦点小组参与者(医护人员和患者)的数据集。
- 采用归纳主题分析识别情境因素并进行跨案例比较。
主要发现
- 识别出三个主要情境影响域:感知感染风险、卫生系统情境和需求侧情境。
- 感知感染风险影响临床使用者(护士、医生)的依从性。
- 卫生系统情境通过卫生政策和抗生素政策环境及卫生系统结构与利用模式影响全部三项干预结局。
- 需求侧情境通过就医行为、疾病与医学观念及卫生系统利用的差异影响患者对CRP即时检测的依从性和干预排除。
临床怎么用
- 解读临床试验结果时应考虑情境变异的影响。
- 临床试验设计应纳入定性及定量情境信息收集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Context matters for the successful implementation of medical interventions, but its role remains surprisingly understudied. Against the backdrop of antimicrobial resistance, a global health priority, we investigated the introduction of a rapid diagnostic biomarker test (C-reactive protein, or CRP) to guide antibiotic prescriptions in outpatient settings and asked, "Which factors account for cross-country variations in the effectiveness of CRP biomarker test interventions?" METHODS: We conducted a cross-case comparison of CRP point-of-care test trials across Yangon (Myanmar), Chiang Rai (Thailand), and Hanoi (Vietnam). Cross-sectional qualitative data were originally collected as part of each clinical trial to broaden their evidence base and help explain their respective results. We synthesised these data and developed a large qualitative data set comprising 130 interview and focus group participants (healthcare workers and patients) and nearly one million words worth of transcripts and interview notes. Inductive thematic analysis was used to identify contextual factors and compare them across the three case studies. As clinical trial outcomes, we considered patients' and healthcare workers' adherence to the biomarker test results, and patient exclusion to gauge the potential "impact" of CRP point-of-care testing on the population level. RESULTS: We identified three principal domains of contextual influences on intervention effectiveness. First, perceived risks from infectious diseases influenced the adherence of the clinical users (nurses, doctors). Second, the health system context related to all three intervention outcomes (via the health policy and antibiotic policy environment, and via health system structures and the ensuing utilisation patterns). Third, the demand-side context influenced the patient adherence to CRP point-of-care tests and exclusion from the intervention through variations in local healthcare-seeking behaviours, popular conceptions of illness and medicine, and the resulting utilisation of the health system. CONCLUSIONS: Our study underscored the importance of contextual variation for the interpretation of clinical trial findings. Further research should investigate the range and magnitude of contextual effects on trial outcomes through meta-analyses of large sets of clinical trials. For this to be possible, clinical trials should collect qualitative and quantitative contextual information for instance on their disease, health system, and demand-side environment. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02758821 registered on 3 May 2016 and NCT01918579 registered on 7 August 2013.
引用
- Haenssgen MJ, Charoenboon N, Do NTT, et al. How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions. Trials. 2019. PMID: 30736818. doi:10.1186/s13063-019-3215-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。